Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): High frequency of small size apolipoprotein(a) isoforms

Journal of Medical Primatology

Volumn 44, Issue 3, 2015, Pages 117-124

  Enkhmaa, Byambaa ^a   Abbuthalha, Adnan ^a   Anuurad, Erdembileg ^a   Zhang, Wei ^a   Tarantal, Alice F ^a,b   Berglund, Lars ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apo(a) phenotype; K4 repeat; Non human primate; Old World monkey

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN; LIPOPROTEIN A; APOLIPOPROTEIN A1;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; FEMALE; GENETIC VARIABILITY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; RHESUS MONKEY; ANIMAL; BLOOD; GENETIC VARIATION; GENETICS; HUMAN; SPECIES DIFFERENCE;

ANIMALIA; CERCOPITHECIDAE; MACACA MULATTA; PRIMATES;

ALLELES; ANIMALS; APOLIPOPROTEIN A-I; GENETIC VARIATION; HUMANS; LIPOPROTEIN(A); MACACA MULATTA; PROTEIN ISOFORMS; SPECIES SPECIFICITY;

EID: 84929296352     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12160     Document Type: Article

References (36)

1. Anuurad E, Lu G, Rubin J, Pearson TA, Berglund L: ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study. J Lipid Res 2007; 48:693-8.
2. Anuurad E, Rubin J, Chiem A, Tracy RP, Pearson TA, Berglund L: High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein (a) levels in African-Americans. J Clin Endocrinol Metab 2008; 93:1482-8.
3. Berg K, Svindland A, Smith AJ, Lawn RM, Djurovic S, Alestrom A, Alestrom P, Eliassen K: Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet. Atherosclerosis 2002; 163:99-104.
4. Bergmark C, Dewan A, Orsoni A, Merki E, Miller ER, Shin MJ, Binder CJ, Horkko S, Krauss RM, Chapman MJ, Witztum JL, Tsimikas S: A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 2008; 49:2230-9.
5. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90:52-60.
6. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM: Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci USA 1994; 91:2130-4.
7. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, Bennett D, Silveira A, Malarstig A, Green FR, Lathrop M, Gigante B, Leander K, de Faire U, Seedorf U, Hamsten A, Collins R, Watkins H, Farrall M: Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361:2518-28.
8. Dembinski T, Nixon P, Shen G, Mymin D, Choy PC: Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a). Mol Cell Biochem 2000; 207:149-55.
9. Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, Kronenberg F, Mueller T: Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem 2007; 53:1298-305.
10. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L: HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol 2013; 33:387-92.
11. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J: Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302:412-23.
12. Erqou S, Thompson A, Di Angelantonio E, Saleheen D, Kaptoge S, Marcovina S, Danesh J: Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58, 000 participants. J Am Coll Cardiol 2010; 55:2160-7.
13. Fan J, Shimoyamada H, Sun H, Marcovina S, Honda K, Watanabe T: Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arterioscler Thromb Vasc Biol 2001; 21:88-94.
14. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG: Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol 2014; 63:470-7.
15. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG: Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32:1732-41.
16. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG: Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009; 301:2331-9.
17. Kronenberg F, Utermann G: Lipoprotein(a): resurrected by genetics. J Intern Med 2013; 273:6-30.
18. Lackner C, Cohen JC, Hobbs HH: Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993; 2:933-40.
19. Laplaud PM, Beaubatie L, Rall SC Jr, Luc G, Saboureau M: Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J Lipid Res 1988; 29:1157-70.
20. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM: Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 1992; 360:670-2.
21. Leibundgut G, Scipione C, Yin H, Schneider M, Boffa MB, Green S, Yang X, Dennis E, Witztum JL, Koschinsky ML, Tsimikas S: Determinants of binding of oxidized phospholipids on apolipoprotein(a) and lipoprotein(a). J Lipid Res 2013; 54:2815-30.
22. Linton MF, Farese RV Jr, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG: Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 1993; 92:3029-37.
23. Makino K, Abe A, Maeda S, Noma A, Kawade M, Takenaka O: Lipoprotein(a) in nonhuman primates. Presence and characteristics of Lp(a) immunoreactive materials using anti-human Lp(a) serum. Atherosclerosis 1989; 78:81-5.
24. Makino K, Noma A, Scanu AM: Rhesus monkey lipoprotein (a). Relationship between Apo(a) isoforms and Lp(a) density in plasma. Ann N Y Acad Sci 1995; 748:603-5.
25. Marcovina SM, Albers JJ, Jacobs DR Jr, Perkins LL, Lewis CE, Howard BV, Savage P: Lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb 1993; 13:1037-45.
26. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996; 37:2569-85.
27. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330:132-7.
28. Mooser V, Scheer D, Marcovina SM, Wang J, Guerra R, Cohen J, Hobbs HH: The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet 1997; 61:402-17.
29. Neven L, Khalil A, Pfaffinger D, Fless GM, Jackson E, Scanu AM: Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptor function. J Lipid Res 1990; 31:633-43.
30. Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A, European Atherosclerosis Society Consensus P: Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31:2844-53.
31. Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L: High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000; 20:2619-24.
32. Rubin J, Kim HJ, Pearson TA, Holleran S, Ramakrishnan R, Berglund L: Apo(a) size and PNR explain African American-Caucasian differences in allele-specific apo(a) levels for small but not large apo(a). J Lipid Res 2006; 47:982-9.
33. Rubin J, Paultre F, Tuck CH, Holleran S, Reed RG, Pearson TA, Thomas CM, Ramakrishnan R, Berglund L: Apolipoprotein (a) genotype influences isoform dominance pattern differently in African Americans and Caucasians. J Lipid Res 2002; 43:234-44.
34. Tomlinson JE, McLean JW, Lawn RM: Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis. J Biol Chem 1989; 264:5957-65.
35. Utermann G: The mysteries of lipoprotein(a). Science 1989; 246:904-10.
36. van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein JJ, Koschinsky ML: The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet 1993; 2:361-6.